Novel genetic Insight into the molecular pathogenesis of atherosclerosis
动脉粥样硬化分子发病机制的新遗传学见解
基本信息
- 批准号:9897648
- 负责人:
- 金额:$ 64.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAddressAffectAortaAortic DiseasesApolipoprotein EArterial Fatty StreakAtherosclerosisBone MarrowBone Marrow TransplantationCarotid ArteriesCell ProliferationCellsChestCholesterolChronicComplexCoronary ArteriosclerosisDefectDifferentiation AntigensDisease ProgressionDissectionEngineeringEtiologyExposure toGKLF proteinGeneticHigh Fat DietIn VitroIndividualInflammationInflammatoryKnock-inKnock-in MouseLeadLesionLipidsMissense MutationModelingMolecularMorbidity - disease rateMusMuscle ProteinsMutant Strains MiceMutationNecrosisOnset of illnessPathogenesisPathway interactionsPhenotypePolymersProliferatingProtein IsoformsResearchRiskRisk FactorsRoleSmooth MuscleSmooth Muscle MyocytesTestingThin FilamentThoracic Aortic AneurysmVariantVascular DiseasesVascular Smooth MuscleWorkalpha Actinatherosclerosis riskcell motilitychaperonin CCTearly onsetexperimental studygenetic manipulationgenetic variantinsightmacrophagemonomermortalitymouse modelmutantnew therapeutic targetnovelpreventtherapeutic targettranscriptome
项目摘要
Atherosclerosis is a chronic inflammatory condition characterized by arterial plaques composed of cholesterol-
filled macrophages, a necrotic lipid core, and a fibrous cap containing vascular smooth muscle cells (SMCs).
Extensive work has defined how genetic variants altering lipid levels and inflammation contribute to
atherosclerosis, but less is known as to how genetic alterations affecting SMCs predispose to atherosclerosis.
An expanded role for SMCs in atherosclerotic lesions is evoked by the finding that SMCs in plaques lose SMC
differentiation markers and initiate expression of macrophage markers, thus becoming a macrophage-like cell.
Similarly, SMCs downregulate SMC markers in vitro, but upregulate macrophage markers with exposure to
free cholesterol. We determined that some heterozygous missense mutations in ACTA2, which encodes the
SMC-specific isoform of α-actin, predispose individuals to both thoracic aortic disease and early onset
coronary artery disease (CAD). We have engineered a mouse model with one such mutation and SMCs
explanted from Acta2R149C/+ aortas de-differentiate and increase expression of macrophage markers at much
lower concentrations of free cholesterol than wildtype SMCs. Furthermore, when the Acta2R149C/+ mice are
crossed into Apoe-/- mice and fed a high fat diet, the double mutant mice have a significantly increased burden
of atherosclerotic plaques when compared to similarly treated Apoe-/- mice. We hypothesize that early onset
CAD associated with the SM α-actin R149C mutation is due to disrupted folding of the mutant actin, leading to
increased Klf4 activation and augmented SMC phenotypic switching to macrophage-like cells. We further
speculate that, although many ACTA2 mutations may increase SMC proliferation and migration, only variants
that increase SMC switching to macrophage-like cells will predispose to early onset CAD. The aims to address
these hypotheses are the following: (1) Characterize the atherosclerotic lesions in the Acta2R149C/+ mice,
including identifying the origin of the SMCs and macrophages in the lesions; (2) Identify cellular pathways
responsible for enhanced Acta2R149C/+ SMC switching to a macrophage-like cell with exposure to cholesterol,
and assess the role of these pathways in the increased plaque burden in Acta2R149C/+ mice through genetic
manipulation. (3) Determine how CAD-associated ACTA2 mutations disrupt folding by the chaperonin CCT
complex, and show causality between SM α-actin folding defects and CAD-predisposing ACTA2 missense
mutations. Thus, the proposed research will provide valuable new insights into the role of SMC phenotypic
switching as a risk factor for atherosclerosis, and may also identify novel therapeutic targets that can delay or
even prevent disease progression.
动脉粥样硬化是一种慢性炎症性疾病,其特征是动脉斑块由胆固醇组成。
充满巨噬细胞、坏死的脂核和含有血管平滑肌细胞(SMCs)的纤维帽。
广泛的研究已经确定了改变血脂水平和炎症的基因变异是如何促成
动脉粥样硬化,但关于影响SMC的基因改变如何易患动脉粥样硬化知之甚少。
斑块中的SMC丢失SMC的发现引发了SMC在动脉粥样硬化病变中作用的扩大
分化标志物并启动巨噬细胞标志物的表达,从而成为巨噬细胞样细胞。
类似地,SMC在体外下调SMC标记,但在暴露于SMC后上调巨噬细胞标记
不含胆固醇。我们确定了ACTA2中的一些杂合错义突变,它编码
SMC特异性α-肌动蛋白亚型易患胸主动脉疾病和早期发病
冠状动脉疾病。我们已经用一种这样的突变和SMC设计了一种小鼠模型
从Acta2R149C/+移植的主动脉在很大程度上去分化和增加巨噬细胞标志物的表达
游离胆固醇浓度低于野生型SMC。此外,当Acta2R149C/+小鼠
与APOE-/-小鼠杂交,并喂食高脂饮食,双突变小鼠的负担显著增加
与类似治疗的APOE-/-小鼠相比,动脉粥样硬化斑块的减少。我们假设早期发病
与SMα-肌动蛋白R149C突变相关的冠心病是由于突变的肌动蛋白折叠中断,导致
KLF4活化增强,SMC表型向巨噬细胞样细胞转化。我们进一步
推测,虽然许多ACTA2突变可能会增加SMC的增殖和迁移,但只有变体
SMC向巨噬细胞样细胞转化增加易发生早发冠心病。其目的是解决
这些假设如下:(1)表征Acta2R149C/+小鼠的动脉粥样硬化病变,
包括确定病变中SMC和巨噬细胞的来源;(2)确定细胞途径
负责增强型Acta2R149C/+SMC向暴露于胆固醇的巨噬细胞样细胞转化,
并评估这些途径在Acta2R149C/+小鼠斑块负荷增加中的作用
操纵。(3)确定与CAD相关的ACTA2突变如何通过伴侣CCT破坏折叠
复杂,并表明SMα-肌动蛋白折叠缺陷与易患冠心病的ACTA2错义之间存在因果关系
突变。因此,拟议的研究将为SMC表型的作用提供有价值的新见解
转换为动脉粥样硬化的危险因素,也可能确定新的治疗靶点,可以延缓或
甚至可以防止疾病的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIANNA M MILEWICZ其他文献
DIANNA M MILEWICZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIANNA M MILEWICZ', 18)}}的其他基金
2023 Elastin, Elastic Fibers and Microfibrils Gordon Research Conference and Gordon Research Seminar
2023年弹性蛋白、弹性纤维和微纤维戈登研究会议和戈登研究研讨会
- 批准号:
10754079 - 财政年份:2023
- 资助金额:
$ 64.03万 - 项目类别:
Novel genetic Insight into the molecular pathogenesis of atherosclerosis
动脉粥样硬化分子发病机制的新遗传学见解
- 批准号:
10360600 - 财政年份:2019
- 资助金额:
$ 64.03万 - 项目类别:
Novel genetic Insight into the molecular pathogenesis of atherosclerosis
动脉粥样硬化分子发病机制的新遗传学见解
- 批准号:
10116456 - 财政年份:2019
- 资助金额:
$ 64.03万 - 项目类别:
UTHealth/MDACC MSTP Alumni Mentoring Program
UTHealth/MDACC MSTP 校友辅导计划
- 批准号:
10394050 - 财政年份:2018
- 资助金额:
$ 64.03万 - 项目类别:
Mutations in Smooth Muscle Contractile Proteins: Pathways to Vascular Diseases
平滑肌收缩蛋白突变:血管疾病的途径
- 批准号:
8898184 - 财政年份:2012
- 资助金额:
$ 64.03万 - 项目类别:
Genetic Predisposition To Thoracic Aortic Aneurysms/Dissections
胸主动脉瘤/夹层的遗传倾向
- 批准号:
8828767 - 财政年份:2012
- 资助金额:
$ 64.03万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 64.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 64.03万 - 项目类别:
Operating Grants